How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapies
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
13 January 2024
|
| In: |
Leukemia
Year: 2024, Jahrgang: 38, Heft: 2, Pages: 465-466 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/s41375-024-02139-4 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41375-024-02139-4 Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41375-024-02139-4 
|
| Verfasserangaben: | Rüdiger Hehlmann and Michael Lauseker |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1881455610 | ||
| 003 | DE-627 | ||
| 005 | 20240307020023.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240222s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41375-024-02139-4 |2 doi | |
| 035 | |a (DE-627)1881455610 | ||
| 035 | |a (DE-599)KXP1881455610 | ||
| 035 | |a (OCoLC)1425200154 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hehlmann, Rüdiger |d 1941- |e VerfasserIn |0 (DE-588)1037003489 |0 (DE-627)751737879 |0 (DE-576)390939463 |4 aut | |
| 245 | 1 | 0 | |a How to individualize therapy after failing milestones in chronic myeloid leukaemia |b weighting late response and early death from CML against risk of alternative therapies |c Rüdiger Hehlmann and Michael Lauseker |
| 264 | 1 | |c 13 January 2024 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 22.02.2024 | ||
| 650 | 4 | |a Chronic myeloid leukaemia | |
| 650 | 4 | |a Randomized controlled trials | |
| 700 | 1 | |a Lauseker, Michael |d 1981- |e VerfasserIn |0 (DE-588)1058710265 |0 (DE-627)79743223X |0 (DE-576)414848438 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 38(2024), 2, Seite 465-466 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a How to individualize therapy after failing milestones in chronic myeloid leukaemia weighting late response and early death from CML against risk of alternative therapies |
| 773 | 1 | 8 | |g volume:38 |g year:2024 |g number:2 |g pages:465-466 |g extent:2 |a How to individualize therapy after failing milestones in chronic myeloid leukaemia weighting late response and early death from CML against risk of alternative therapies |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41375-024-02139-4 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41375-024-02139-4 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240222 | ||
| 993 | |a Editorial | ||
| 994 | |a 2024 | ||
| 998 | |g 1037003489 |a Hehlmann, Rüdiger |m 1037003489:Hehlmann, Rüdiger |d 60000 |e 60000PH1037003489 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1881455610 |e 4490101147 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 22.02.2024"],"recId":"1881455610","person":[{"display":"Hehlmann, Rüdiger","given":"Rüdiger","family":"Hehlmann","role":"aut"},{"given":"Michael","display":"Lauseker, Michael","family":"Lauseker","role":"aut"}],"language":["eng"],"name":{"displayForm":["Rüdiger Hehlmann and Michael Lauseker"]},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"13 January 2024"}],"relHost":[{"pubHistory":["Nachgewiesen 11.1997 -"],"note":["Gesehen am 15.03.04"],"part":{"year":"2024","volume":"38","issue":"2","extent":"2","pages":"465-466","text":"38(2024), 2, Seite 465-466"},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"How to individualize therapy after failing milestones in chronic myeloid leukaemia weighting late response and early death from CML against risk of alternative therapiesLeukemia","recId":"32046699X","origin":[{"publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedDisp":"1997-","dateIssuedKey":"1997","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke"}],"id":{"eki":["32046699X"],"issn":["1476-5551"],"zdb":["2008023-2"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Leukemia","title":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal"}]}],"physDesc":[{"extent":"2 S."}],"id":{"eki":["1881455610"],"doi":["10.1038/s41375-024-02139-4"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"subtitle":"weighting late response and early death from CML against risk of alternative therapies","title":"How to individualize therapy after failing milestones in chronic myeloid leukaemia","title_sort":"How to individualize therapy after failing milestones in chronic myeloid leukaemia"}]} | ||
| SRT | |a HEHLMANNRUHOWTOINDIV1320 | ||